Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Clinical trial NCT02914613 · COMPLETED
Trial details
- NCT number
- NCT02914613
- Sponsor
- OcuTerra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-24
- Primary completion
- 2017-05-16
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.